Sci Rep. 2025 Jun 6;15(1):20025. doi: 10.1038/s41598-025-02536-4.
ABSTRACT
Collagen is critical to the structure and function of skin tissues, with the collagen I/III ratios influencing fibrillogenesis, fiber organization, and skin mechanics. Abnormal collagen organization, such as in fibrosis or scar tissue, compromises both skin functionality and aesthetics. In this study, we employed label-free polarization resolved second harmonic generation (PSHG) microscopy to investigate collagen structure in artificial collagen matrices with various Col I/III ratios at the fibril scale ( 1 to ) and in ex vivo human healthy and scarred skin at the fiber scale ( to ). Complementary third harmonic generation (THG) microscopy provided additional structural information. Our results indicate that an increasing Col I/III ratio is associated with longer fibril length, higher PSHG intensity, and a reduced effective -helix pitch angle of fibrils. In pure Col I, the effective -helix pitch angle is determined to be . These observations indicate alterations in fibril assembly. Furthermore, although the -helix pitch angle of fibers in both healthy and scarred skin was approximately , healthy skin exhibited greater variability in fiber orientation, suggesting a more randomized organization compared to scar tissue. THG imaging further revealed a higher cellular density in scar tissue, consistent with the inflammatory activity associated with wound healing. Immunohistochemical (IHC) staining using dermatansulphate and Col III-specific antibodies confirmed that the Col I/III ratio is higher in healthy skin (2.2) than in scarred skin (1.6). These findings underscore the potential of PSHG microscopy for label-free, quantitative assessment of collagen structure across multiple scales, with THG offering complementary cellular insights. This integrated approach represents a promising strategy for real-time, in vivo monitoring and automated quantification of collagen organization in clinical applications, including dermatology, burn treatment, and fibrosis monitoring.
PMID:40481016 | PMC:PMC12144187 | DOI:10.1038/s41598-025-02536-4